Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Personalized Diabetes Medicine Program, |
RCV001174373 | SCV001337511 | uncertain significance | Monogenic diabetes | 2019-02-22 | criteria provided, single submitter | research | ACMG criteria: PM2 (extremely low frequency in gnomAD)= VUS (REVEL 0.513 + PP3/7 predictors + BP4/2 predictors= conflicting evidence, not using) |
Clinical Genomics, |
RCV002227252 | SCV002505473 | uncertain significance | Transitory neonatal diabetes mellitus | criteria provided, single submitter | research | Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. It is also associated with Neonatal Diabetes. However, no sufficient evidence is found to ascertain the role of rs745379486 variant in MODY yet. | |
Fulgent Genetics, |
RCV002505753 | SCV002816376 | uncertain significance | Diabetes mellitus, transient neonatal, 3; Hyperinsulinemic hypoglycemia, familial, 2; Type 2 diabetes mellitus; Maturity-onset diabetes of the young type 13; Diabetes mellitus, permanent neonatal 2 | 2021-10-05 | criteria provided, single submitter | clinical testing |